Mercer Global Advisors’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $323K | Buy |
3,044
+1,332
| +78% | +$141K | ﹤0.01% | 1782 |
|
2025
Q1 | $213K | Buy |
1,712
+71
| +4% | +$8.82K | ﹤0.01% | 1938 |
|
2024
Q4 | $202K | Sell |
1,641
-1,686
| -51% | -$208K | ﹤0.01% | 1968 |
|
2024
Q3 | $371K | Sell |
3,327
-158
| -5% | -$17.6K | ﹤0.01% | 1514 |
|
2024
Q2 | $372K | Buy |
3,485
+1,187
| +52% | +$127K | ﹤0.01% | 1470 |
|
2024
Q1 | $277K | Sell |
2,298
-365
| -14% | -$44K | ﹤0.01% | 1609 |
|
2023
Q4 | $328K | Sell |
2,663
-112
| -4% | -$13.8K | ﹤0.01% | 1554 |
|
2023
Q3 | $359K | Buy |
2,775
+79
| +3% | +$10.2K | ﹤0.01% | 1418 |
|
2023
Q2 | $334K | Sell |
2,696
-632
| -19% | -$78.3K | ﹤0.01% | 1452 |
|
2023
Q1 | $487K | Sell |
3,328
-625
| -16% | -$91.5K | ﹤0.01% | 1219 |
|
2022
Q4 | $630K | Sell |
3,953
-111
| -3% | -$17.7K | ﹤0.01% | 1101 |
|
2022
Q3 | $542K | Sell |
4,064
-505
| -11% | -$67.4K | ﹤0.01% | 1096 |
|
2022
Q2 | $713K | Sell |
4,569
-257
| -5% | -$40.1K | ﹤0.01% | 984 |
|
2022
Q1 | $751K | Sell |
4,826
-1,722
| -26% | -$268K | ﹤0.01% | 1027 |
|
2021
Q4 | $834K | Sell |
6,548
-599
| -8% | -$76.3K | 0.01% | 968 |
|
2021
Q3 | $931K | Sell |
7,147
-4,114
| -37% | -$536K | 0.01% | 887 |
|
2021
Q2 | $2M | Sell |
11,261
-515
| -4% | -$91.5K | 0.02% | 571 |
|
2021
Q1 | $1.94M | Sell |
11,776
-617
| -5% | -$101K | 0.02% | 530 |
|
2020
Q4 | $2.05M | Sell |
12,393
-24,223
| -66% | -$4M | 0.03% | 414 |
|
2020
Q3 | $5.22M | Sell |
36,616
-163
| -0.4% | -$23.2K | 0.08% | 192 |
|
2020
Q2 | $4.06M | Buy |
36,779
+8,779
| +31% | +$969K | 0.07% | 194 |
|
2020
Q1 | $2.79M | Buy |
28,000
+24,919
| +809% | +$2.49M | 0.06% | 252 |
|
2019
Q4 | $460K | Buy |
3,081
+336
| +12% | +$50.2K | 0.01% | 760 |
|
2019
Q3 | $351K | Sell |
2,745
-82
| -3% | -$10.5K | 0.01% | 837 |
|
2019
Q2 | $403K | Buy |
2,827
+258
| +10% | +$36.8K | 0.01% | 760 |
|
2019
Q1 | $367K | Buy |
+2,569
| New | +$367K | 0.01% | 749 |
|